 Paul Taaffe |
Britain's Huntsworth today announced the acquisition of a 90.2 percent stake in Giant Creative Holdings healthcare marketing communications from Shamrock Capital Growth Fund for $72.2M in cash.
San Francisco-based Giant Creative Strategy's 150 staffers serve clients in the biopharmaceutical, medical device and diagnostics sectors.
The firm recorded $32M in 2017 revenues and $7M in profit (EBITDA).
GCS CEO Steven Gold, president Adam Gelling and senior management own the remaining 9.8 percent stake of the firm. Huntsworth may spend up to $25M to purchase the management stock based on GCS' earnings performance.
Huntsworth CEO Paul Taaffe said the GCS deal adds scale in healthcare professional marketing especially in the fast growth biotech sector. “This expansion of Huntsworth makes it an even more compelling alternative to the large holding company networks,” he said.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
